![]() ACell ACell is a company focused on the development and commercialization of medical devices for wound management and surgical soft tissue repair. | ![]() Xtant Medical Xtant Medical develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. | ![]() Organogenesis Organogenesis is a leader in regenerative medicine, specializing in bio-active wound healing and oral regeneration. | |
Founding Date | Founding Date 2002 | Founding Date 2006 | Founding Date 1985 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Columbia, US HQ Lafayette, US | Locations Belgrade, US HQ Miamisburg, US | Locations Canton, US HQ Kanton Reinach, CH Canton, US San Diego, US |
Employees | Employees 400 | Employees 14115% decrease | Employees 9791% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 77.1 m | Valuation ($) 395.1 m |
Financial | |||
Revenue (est.) | Revenue (est.) $100.8m (FY, 2019) | Revenue (est.) $133.9m (FY, 2025) | Revenue (est.) $564.2m (FY, 2025) |
Cost of goods | Cost of goods $19.1m (FY, 2019) | Cost of goods $49.7m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $81.7m (FY, 2019) | Gross profit $84.3m (FY, 2025) | Gross profit N/A |
Net income | Net income $1.4m (FY, 2019) | Net income $5m (FY, 2025) | Net income $37m (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 8.7m | Total funding raised N/A | Total funding raised $ 75m |

Xtant Medical develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets.
View company
Organogenesis is a leader in regenerative medicine, specializing in bio-active wound healing and oral regeneration.
View company